Latest Stool tests Stories

Request A Test has expanded their lab test selection to include stool testing. Now customers can order affordable, convenient stool tests to aid in the diagnosis of various digestive disorders. Brecksville, OH (PRWEB) May 17, 2013 Request A Test, a national direct to consumer lab testing company, is now offering a new category for Stool Testing. While it may be unpleasant to think about, the testing of stool samples can be a valuable tool in aiding in the diagnosis of a number of...

Screening rates increase even more when doctors discuss details of screening tests, Kaiser Permanente study finds PORTLAND, Ore., April 29, 2013 /PRNewswire/ -- Patients who visited their doctor for any reason were nearly six times more likely to get screened for colon cancer compared to those who didn't visit their doctor, according to a study funded by the National Cancer Institute and published online today in the American Journal of Managed Care. The study was conducted in an...

Blood-based test identifies 9 out of 10 people with previously undetected colorectal cancer. SALT LAKE CITY, March 22, 2013 /PRNewswire/ -- March is National Colorectal Cancer Awareness Month and an ideal time to highlight the importance of colon health and screening. Doctors recommend that everyone age 50 and up participate in regular colorectal cancer screening, but since approximately half the population opts out, nearly 40 million Americans are left unscreened every year....

By the National Cancer Institute Editor's Note: The following article is part of the monthly Lifelines education and awareness print series that the National Cancer Institute provides to African American news and information outlets. BETHESDA, Md., March 15, 2013 /PRNewswire-USNewswire/ -- If a screening test could not only catch cancer early but also help to prevent it, could you think of any reason not to have the test? (Logo:...

OAK BROOK, Ill., Dec. 19, 2012 /PRNewswire-USNewswire/ -- A new year is approaching and for those that are turning 50 in 2013, the American Society for Gastrointestinal Endoscopy (ASGE) recommends adding colorectal cancer screening to their New Year's list of resolutions. Recent studies have confirmed that screening is a contributing factor to declining colorectal cancer death rates. Colorectal cancer, also referred to as colon cancer, is one of the most preventable cancers. The...

A study presented today by Mayo Clinic researchers at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago identified two genes that are optimal targets to be analyzed in a new noninvasive test for colorectal cancer developed by Mayo Clinic, in collaboration with Exact Sciences Corporation. The test uses a small sample of a patient's stool to check for specific DNA changes, known as gene methylation, that occur as cancer develops. The test can quickly detect both...

Noninvasive stool test for colorectal cancer unaffected by medications, lifestyle factors and other variables Research on an investigational DNA methylation test for colorectal cancer demonstrated that the only clinical variable that influenced test results was age, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4. "There was a progressive increase in background methylation levels that varied widely between methylation markers tested as a...

Results of two studies suggest that a new, investigational colorectal cancer screening test developed in a collaboration between Mayo Clinic and Exact Sciences Inc. of Madison, Wis., is highly accurate and significantly more sensitive than other noninvasive tests at detecting precancerous tumors (adenomas) and early-stage cancer. These findings have important implications for clinicians and tens of thousands of Americans. Early detection is a key driver of better outcomes for colorectal...

CORTLANDT MANOR, N.Y., Aug. 17, 2011 /PRNewswire/ -- Polymedco is pleased to announce a publication in Epidemiologic Review, "Organized Colorectal Cancer Screening in Integrated Health Care Systems" by Theodore R Levin, Laura Jamieson, Daniel A Burley, Juan Reyes, Michael Oehrli, and Cindy Caldwell (Epidemiol Rev (2011)33(1);101-110). The publication details the organized screening program for Colorectal cancer (CRC) at Kaiser Permanente Northern California (KPNC). The CRC screening...

The immunochemical fecal occult blood test (iFOBT) is effective for predicting lesions in the lower intestine but not in the upper gastrointestinal (GI) tract, confirms a study in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj101248.pdf.The immunochemical fecal occult blood test is a useful noninvasive tool to screen for bleeding without symptoms in the lower GI tract. If bleeding is discovered, a colonoscopy is then used to...